埃塞俄比亚瘤紧急情况的流行病学:系统性审查和元分析
Astewle Andargie Baye1, Gebre Kassaw Yirga2, Yirgalem Abere2
1Department of Adult Health Nursing, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia. astewlea@gmail.com.
BMC emergency medicine
|December 7, 2025
概括
埃塞俄比亚瘤紧急情况的综合流行率为30.87%,对癌症患者产生重大影响. 早期发现和及时干预对于减轻这种负担至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 瘤紧急情况给患者和护理人员带来了重大挑战.
- 关于瘤紧急情况的规模的现有文献是分散的和不一致的.
- 对于有效的医疗保健规划,全面了解瘤紧急情况的流行率至关重要.
研究的目的:
- 确定埃塞俄比亚瘤紧急情况的总体规模.
- 为提供瘤紧急情况的综合流行率估计.
- 为了确定癌症紧急情况的预测因素.
主要方法:
- 进行了全面的文献搜索.
- 使用DerSimonian-Laird进行了一项随机效应元分析.
- 使用I2统计数据评估异质性,并进行子组和灵敏度分析.
主要成果:
- 分析包括23项研究,涉及6755名癌症患者.
- 埃塞俄比亚瘤紧急情况的综合流行率为30.87% (95% CI: 23.72-38.02).
- 重要的预测因素包括并发症,晚年,正在进行的癌症治疗和转移.
结论:
- 早期发现和及时干预对于减少瘤紧急情况的影响至关重要.
- 在不同研究中对瘤紧急情况的定义和测量的变化是一个挑战.
相关概念视频
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Statistical Methods for Analyzing Epidemiological Data
875
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
875
Hazard Ratio
549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
549
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Introduction to Epidemiology
1.6K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.6K
Comparing the Survival Analysis of Two or More Groups
538
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
538

